Ovarian cancer is the 6th most common cancer in women in the UK, with around 7,500 people diagnosed each year. There are many types of ovarian cancer, with epithelial ovarian cancer as the most common. This develops from cells on the surface of the ovary and includes many sub-types.
Ovarian cancer symptoms are vague and often misdiagnosed as other conditions, like Irritable Bowel Syndrome (IBS). Ovarian cancers are too often diagnosed in the later stages. This can make treatment options more challenging and reduces the chance of a positive outcome. The National Ovarian Cancer Audit: State of the Nation report 2025 found that around three in four women in England and Wales are diagnosed at stage 2–4.
Professor Christina Fotopoulou and her team hope to create an innovative way to detect epithelial ovarian cancer in the early stages.
Currently, even with multiple large-scale research studies, there is still no screening available for ovarian cancer. Most of the current research has focused on traditional methods for cancer detection, like an ultrasound. We now know that the most common type of ovarian cancer, high grade serous, starts in the top of the fallopian tubes.
As the fallopian tube is very small, current tests have not been able to spot ovarian cancer in the early stages. This means that the cancer can remain undiagnosed for months or even years. When tumours are big enough to be detected in scans, it’s often too late for an early-stage diagnosis as the cells have left the tubes and been able to spread.

Professor Christina Fotopoulou with Dr Paula Cunnea and their team aim to look directly at the source of the cancer and collect cell changes from the fallopian tubes. With their collaborators, Professor Julian Jones (Imperial) and Dr Paul Jones (Xeparate), they have developed a foam-like tool, similar to a sponge, that collects different cell types from fluids. They hope to adapt the sponge to be inserted into the fallopian tube through the vagina and then test these samples to detect any precancerous or cancerous cells.
This project will test how well these sponges are able to capture the cells that can cause cancer. The team hopes that if this research is successful, it could one day lead to a screening test for ovarian cancer. This would mean that ovarian cancer would be able to be detected before symptoms occur.
If this novel bio-functional swab is successful we may finally be able to find a screening method that can diagnose ovarian cancer at its earliest stages through a non-traumatic, day-case procedure.
-Prof Christina Fotopoulou
More information
We have lots more information on our current research projects and ovarian cancer. You can also speak to our Ask Eve nurses for free to chat about any worries or questions.